📣 VC round data is live. Check it out!
- Public Comps
- NDFOS Co
NDFOS Co Valuation Multiples
Discover revenue and EBITDA valuation multiples for NDFOS Co and similar public comparables like PBG, Concejo, Borgestad, Meta Wolf and more.
NDFOS Co Overview
About NDFOS Co
NDFOS Co Ltd is engaged in double-sided tapes for mobile devices, targeting mobile phone manufacturers, while the window film business focuses on exports through various overseas business partners. Its business divisions are the FILM Business Division and the TAPE Business Division.
Founded
2010
HQ

Employees
169
Website
Sectors
Financials (FY)
EV
$45M
Valuation Multiples
Start free trialNDFOS Co Financials
NDFOS Co reported last fiscal year revenue of $35M and EBITDA of $6M.
In the same fiscal year, NDFOS Co generated $12M in gross profit, $6M in EBITDA, and $4M in net income.
NDFOS Co P&L
In the most recent fiscal year, NDFOS Co reported revenue of $35M and EBITDA of $6M.
NDFOS Co is profitable as of last fiscal year, with gross margin of 36%, EBITDA margin of 19%, and net margin of 10%.
Financial data powered by Morningstar, Inc.
NDFOS Co Stock Performance
NDFOS Co has current market cap of $59M, and enterprise value of $45M.
NDFOS Co's stock price is $2.60.
NDFOS Co has an EPS (earnings per share) of $0.16.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $45M | $59M | -0.4% | — | — | — | $0.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNDFOS Co Valuation Multiples
NDFOS Co trades at 1.3x EV/Revenue multiple, and 6.9x EV/EBITDA.
NDFOS Co Financial Valuation Multiples
As of May 10, 2026, NDFOS Co has market cap of $59M and EV of $45M.
NDFOS Co has a P/E ratio of 16.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified NDFOS Co Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


NDFOS Co Margins & Growth Rates
In the most recent fiscal year, NDFOS Co reported gross margin of 36%, EBITDA margin of 19%, and net margin of 10%.
NDFOS Co Margins
NDFOS Co Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
NDFOS Co Operational KPIs
NDFOS Co's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
NDFOS Co Competitors
NDFOS Co competitors include PBG, Concejo, Borgestad, Meta Wolf, Lentex, 3U Holding, Ferrum, Hutter und Schrantz Steel, Poujoulat and Iktinos Hellas.
Most NDFOS Co public comparables operate across Building Products.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.8x | — | 10.1x | — | |||
| 0.9x | — | 6.0x | — | |||
| 0.8x | 0.8x | 9.5x | 8.1x | |||
| 0.5x | — | 64.9x | — | |||
| 0.6x | — | 4.6x | — | |||
| 0.5x | 0.5x | 5.6x | (87.2x) | |||
| 1.0x | — | 6.9x | — | |||
| 0.1x | — | 1.5x | — | |||
This data is available for Pro users. Sign up to see all NDFOS Co competitors and their valuation data. Start Free Trial | ||||||
NDFOS Co Investment Activity
NDFOS Co has invested in 1 company to date.
Latest investment by NDFOS Co was on February 19th 2020. NDFOS Co invested in NeoTX Therapeutics in their $45M Series C round (EV/Revenue multiple of ).
Latest Investments by NDFOS Co
| Description | NeoTX Therapeutics is a Tel Aviv-based biopharmaceutical company advancing oncology immunotherapies. Its pipeline features proprietary tumor-targeted antibodies and bispecific molecules designed to enhance immune responses against solid tumors, developed through internal research and partnerships with academic institutions in Israel. |
| HQ Country | |
| HQ City | Rehovot |
| Deal Date | 19 Feb 2020 |
| Round | Series C |
| Raised | $45M |
| Investors | J. Tomilson Hill; Maurice R. Greenberg; NDFOS; Tako Ventures |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all NDFOS Co investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout NDFOS Co
| When was NDFOS Co founded? | NDFOS Co was founded in 2010. |
| Where is NDFOS Co headquartered? | NDFOS Co is headquartered in South Korea. |
| How many employees does NDFOS Co have? | As of today, NDFOS Co has over 169 employees. |
| Is NDFOS Co publicly listed? | Yes, NDFOS Co is a public company listed on Korea Exchange. |
| What is the stock symbol of NDFOS Co? | NDFOS Co trades under 238090 ticker. |
| When did NDFOS Co go public? | NDFOS Co went public in 2016. |
| Who are competitors of NDFOS Co? | NDFOS Co main competitors include PBG, Concejo, Borgestad, Meta Wolf, Lentex, 3U Holding, Ferrum, Hutter und Schrantz Steel, Poujoulat, Iktinos Hellas. |
| What is the current market cap of NDFOS Co? | NDFOS Co's current market cap is $59M. |
| What is the current revenue of NDFOS Co? | NDFOS Co's last fiscal year revenue is $35M. |
| What is the current EV/Revenue multiple of NDFOS Co? | Current revenue multiple of NDFOS Co is 1.3x. |
| Is NDFOS Co profitable? | No, NDFOS Co is not profitable. |
| How many companies NDFOS Co has acquired to date? | NDFOS Co hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies NDFOS Co has invested to date? | As of May 2026, NDFOS Co has invested in 1 company. |
| What was the last NDFOS Co investment? | On 19th February 2020 NDFOS Co invested in NeoTX Therapeutics, participating in a $45M Series C round, alongside J. Tomilson Hill, Maurice R. Greenberg, NDFOS, and Tako Ventures. |
| In what companies NDFOS Co invested in? | NDFOS Co invested in NeoTX Therapeutics. |
See public comps similar to NDFOS Co
Lists including NDFOS Co
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
